Bolt Biotherapeutics to Acquire Prana Therapies, Raises $120 Million in Private Placement
Bolt announced the acquisition of Prana Therapies and a concurrent $120 million private placement to advance PRA-216 in inflammatory indications.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
2 results loaded, newest first. End of these results.
Bolt Biotherapeutics to Acquire Prana Therapies, Raises $120 Million
Bolt Biotherapeutics announced the acquisition of Prana Therapies and a concurrent $120 million private placement to advance PRA-216 in inflammatory indications.